Xponential Fitness, Inc. XPOF
3.92
0.17
4.53%
as of 25 Sep
- Market cap
- $184.7M
- P/E
- 0.0×
Follow XPOF
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.87 | 0.91 | 0.75 | 1.01 | |
P/FCF ratio |
17.26 | 9.60 | 94.35 | 0.00 | |
P/Operating CF |
29.41 | 26.83 | (10.36) | (72.03) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.88 | 2.37 | 2.37 | 2.71 | |
EV/EBITDA |
9.85 | 10.29 | 9.74 | 15.07 | |
EV/Operating CF |
32.10 | 26.36 | 873.52 | (135.76) | |
EV/FCF |
37.31 | 25.01 | 297.53 | (271.53) | |
Quick Ratio |
0.64 | 0.55 | 0.43 | 0.46 | |
Current Ratio |
1.06 | 0.82 | 0.76 | 0.75 | |
Net Debt/EBITDA |
(60.71) | 16.02 | 29.95 | 40.27 | |
Debt/Assets |
101.05% | 146.33% | 156.71% | 166.14% | |
Debt/Equity |
(1.12) | (1.36) | (1.36) | (1.37) | |
Asset Turnover |
0.76 | 0.84 | 0.81 | 0.81 | |
Operating CF/Net income |
(1.91) | (0.24) | 29.92 | 0.98 | |
Capex/Depreciation |
(0.06) | 0.10 | (0.26) | (0.24) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
42.69% | 85.58% | 68.71% | 65.90% | |
Intangible Assets out of Total Assets |
0.55 | 0.56 | 0.60 | 0.62 | |
Share Based Compensation of Revenue |
3.04% | 5.50% | 3.27% | 2.58% | |
Graham Net Nets |
(2.11) | (2.17) | (2.76) | (2.12) | |
Graham Number |
18.41 | 18.74 | 17.59 | 17.20 | |
Earnings Yield |
(21.18%) | (17.74%) | (22.92%) | (21.24%) | |
Free Cash Flow Yield |
5.79% | 10.42% | 1.06% | (0.99%) | |
Revenue per Share |
2.25 | 2.38 | 1.63 | 1.57 | |
Operating CF per Share |
0.26 | 0.31 | (0.58) | (0.10) | |
Capex per Share |
0.01 | 0.11 | (0.02) | (0.01) | |
Free Cash Flow per Share |
0.28 | 0.42 | (0.60) | (0.11) | |
Cash per Share |
1.18 | 1.32 | 0.58 | 0.59 | |
Shareholders Equity per Share |
(9.13) | (10.69) | (9.97) | (8.95) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(9.13) | (10.69) | (9.97) | (8.95) | |
Free Cash Flow |
9.80 | 14.50 | (22.51) | (4.66) | |
Working Capital |
5.99 | (21.33) | (24.03) | (23.57) | |
Capital Expenditures |
0.50 | 3.82 | (0.82) | (0.63) | |
Net Current Asset Value |
(576.59) | (622.94) | (619.39) | (616.55) | |
EV/EBIT |
0.00 | 37.60 | 30.52 | 43.60 | |
Capex to Sales |
(0.01) | (0.05) | 0.01 | 0.01 | |
Net Profit Margin |
(6.16%) | (54.63%) | (1.19%) | (6.27%) | |
Price to Operating Income |
0.00 | 14.43 | 9.68 | 16.25 | |
| Other line items | |||||
Average Receivables |
24.10 | 22.17 | 24.85 | 27.06 | |
Average Payables |
18.44 | 26.65 | 22.87 | 19.53 | |
Average Inventory |
8.13 | 6.12 | 5.41 | 5.17 | |
Average Assets |
413.74 | 374.52 | 367.43 | 354.83 | |
Average Common Equity |
(280.33) | (341.38) | (342.84) | (344.63) |
Columns are period end dates